At the 36mg dose, participants lost an average of 11.2% body weight over 72 weeks
The accumulation of senescent cells, often referred to as the "old cell burden," is a concern because these cells can secrete a variety of harmful substances as part of the senescence-associated secretory phenotype (SASP)
When AOD-9604 Fat Cell Targeting is Most Effective The AOD-9604 approach to fat cell targeting is particularly well-suited for individuals who have achieved good metabolic health through diet and exercise but struggle with stubborn fat deposits, those seeking selective fat loss without appetite suppression or systemic metabolic changes, athletes or active individuals who need to maintain training capacity and muscle mass during fat loss phases, individuals who cannot tolerate or are contraindicated for GLP-1 agonists or growth hormone therapy, and those seeking a research-backed, clinically-studied option with established safety data from human trials
PMID 11148506
Because of its well-defined structure, it allows scientists to test hypotheses about copper-binding kinetics , metal exchange rates, and spectroscopic fingerprints
